Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amorfix Life Science (ARFXF)

Amorfix Life Science (ARFXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Amorfix Life Science 1920 Yonge Street Suite 200 Toronto A6 M4S 3E2 CAN

www.promisneurosciences.com P: 416-847-6898

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

ProMIS Neurosciences Inc. is a development stage biotechnology company. It focused on discovering and developing medicine therapeutics to treat neurodegenerative diseases in particular Alzheimer's disease and amyotrophic lateral sclerosis. The company's product portfolio includes PMN310, PMN350, PMN330, PMN110, PMN120 and PMN130 which are in its pre-clinical stage. ProMIS Neurosciences Inc.is headquartered in Toronto, Canada.

Key Statistics

Overview:

Market Capitalization, $K 44,037
Enterprise Value, $K 44,023
Shares Outstanding, K 431,732
Float, K 431,732
% Float 100.00%
Short Volume Ratio 0.74
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 10 K
Annual Net Income, $ -9,400 K
Last Quarter Sales, $ 10 K
Last Quarter Net Income, $ -2,430 K

Growth:

1-Year Return -40.84%
3-Year Return -37.04%
5-Year Return -42.76%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 05/13/22
Next Earnings Date 08/11/22
Earnings Per Share ttm -0.01
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ARFXF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -227.36%
Return-on-Assets % -37.30%
Profit Margin % -94,000.00%
Debt/Equity 1.08
Price/Sales 2,201.85
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.01
Interest Coverage -21.38
60-Month Beta 1.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar